SARS-CoV-2 acute respiratory disease
Clinical trials for SARS-CoV-2 acute respiratory disease explained in plain language.
Never miss a new study
Get alerted when new SARS-CoV-2 acute respiratory disease trials appear
Sign up with your email to follow new studies for SARS-CoV-2 acute respiratory disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COVID booster shows promise in Mix-and-Match trial
Vaccine CompletedThis study tested a new booster vaccine called PHH-1V in 887 adults who had already received two doses of the Pfizer COVID-19 vaccine. The goal was to see if the new booster was as safe and effective as a third Pfizer dose. The trial also looked at the effects of a fourth dose of…
Matched conditions: SARS-COV-2 ACUTE RESPIRATORY DISEASE
Phase 2 • Sponsor: Hipra Scientific, S.L.U • Aim: Vaccine
Last updated Jun 27, 2026 11:01 UTC
-
Heartburn and arthritis drugs tested against COVID-19
Disease control CompletedThis Phase 2 trial tested whether combining famotidine (Pepcid) and celecoxib (Celebrex) could help people with COVID-19 recover faster. Only 4 participants were enrolled, making it too small to draw firm conclusions. The study aimed to see if these drugs could reduce symptom sev…
Matched conditions: SARS-COV-2 ACUTE RESPIRATORY DISEASE
Phase 2 • Sponsor: Leidos Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC